/Companies

Creoptix

Wädenswil, CH · 2 known investors

Find your way into Creoptix

Sign up to see every warm intro you have to Creoptix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Creoptix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Creoptix, a Malvern Panalytical brand, develops bioanalytical instruments for molecular interaction analysis, including its WAVE biosensor system for real-time kinetics and affinity studies of molecules such as small molecules, peptides, and proteins. Its tools serve drug discovery and life sciences research for both industry and academia.

Founders & leadership

KCKaspar Cottier
Kaspar CottierCTO, Founder2010–2021Founder of Creoptix, a developer of bioanalytical instruments for molecular interaction analysis. Also invests in and serves as a board member for technology startups.

Investors · 2

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Creoptix do?
Creoptix, a Malvern Panalytical brand, develops bioanalytical instruments for molecular interaction analysis, including its WAVE biosensor system for real-time kinetics and affinity studies of molecules such as small molecules, peptides, and proteins. Its tools serve drug discovery and life sciences research for both industry and academia.
Who founded Creoptix?
Creoptix was founded by Kaspar Cottier.
Who are Creoptix's investors?
Creoptix's investors include Privilège Ventures, StartAngels Network.
Where is Creoptix headquartered?
Creoptix is headquartered in Wädenswil, CH.